David W. Nassif - 18 Mar 2026 Form 3 Insider Report for Pharvaris N.V. (PHVS)

Role
CFO / CLO
Signature
/s/ Marnus Nel, Attorney-in-Fact for David Nassif
Issuer symbol
PHVS
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 14:23:34 UTC
Previous filing
10 Feb 2022
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nassif David W. CFO / CLO 1 CRANBERRY HILL SUITE 400, LEXINGTON, LEXINGTON /s/ Marnus Nel, Attorney-in-Fact for David Nassif 18 Mar 2026 0001636975

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PHVS Common Stock 123,925 18 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PHVS Stock Option (Right to Buy) 18 Mar 2026 Common Stock 60,000 $28.00 Direct F2
holding PHVS Stock Option (Right to Buy) 18 Mar 2026 Common Stock 60,000 $16.05 Direct F3
holding PHVS Stock Option (Right to Buy) 18 Mar 2026 Common Stock 75,000 $15.94 Direct F4
holding PHVS Stock Option (Right to Buy) 18 Mar 2026 Common Stock 230,000 $20.15 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units previously granted under the Company's equity plan that remain outstanding as of March 18, 2026. The awards settle in shares of common stock and are reported in Table I as non-derivative securities. Vesting occurs as follows: -20,000 RSUs from an award granted March 3, 2026 of which 25% will vest March 3, 2027 with the remainder vesting monthly thereafter; -15,000 RSUs from an award granted March 12, 2025 of which 25% vested March 12, 2026 with the remainder vesting monthly thereafter; -14,198 RSUs from an award granted August 1, 2024 of which 25% vested August 1, 2025 with the remainder vesting monthly thereafter; -35,750 RSUs from an award granted April 15, 2024 of which 25% vested April 15, 2025 with the remainder vesting monthly thereafter;
F2 25% of the option will vest on March 3, 2027 with the remaining shares vesting in 1/48 monthly installments thereafter.
F3 25% of the option vested on March 12, 2026 with the remaining shares vesting in 1/48 monthly installments thereafter.
F4 25% of the option vested on August 1, 2025 with the remaining shares vesting in 1/48 monthly installments thereafter.
F5 25% of the option vested on April 15, 2025 with the remaining shares vesting in 1/48 monthly installments thereafter.